{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/DK0060775872",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Initiator Pharma A/S (First North Sweden: DK0060775872) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Initiator Pharma A/S, listed on First North Sweden under ticker DK0060775872, with ISIN DK0060775872 and LEI 213800DFI4I1A5RVKB59. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 19 filings in the twelve months to 2026-11-06, across 15 filing days. The median gap between filing days is 20.5 days. The latest filing is dated 2026-10-28 and is of type Investor News, 9 days before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers. Sector medians are not on the record for this market.\n\n## Auditor\n\nThe auditor of record, its location and any auditor changes are not on the record.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move events for this register. The halt flag is listed, not halted.\n\n## Orderability\n\nThe client category outcome is not determinable because the chapter's orderability section carries no client categories. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nFour research houses are named on the issuer's investor-relations page: DNB Carnegie, Redeye, DNB and Carnegie.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed for this market. No issuer years are sealed, the market earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/DK0060775872 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/ (coverage)\n- https://mcp.se-cm-kg.ai/record/SSME/DK0060775872 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/DK0060775872",
  "coverage": {
   "count": 4,
   "houses": [
    {
     "house": "DNB Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/",
     "state": "sourced"
    },
    {
     "house": "Redeye",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/",
     "state": "sourced"
    },
    {
     "house": "DNB",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/",
     "state": "sourced"
    },
    {
     "house": "Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/",
     "result": "read: 4 of 5 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Decisions of general meeting": 1,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Interim report (Q1 and Q3)": 3,
    "Investor News": 11,
    "Notice to general meeting": 1
   },
   "cadence_median_gap_days": 20.5,
   "filing_days": 15,
   "filings": 19,
   "latency_days": 9,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b1182e616f68305989df81520b6e602d8&lang=en&src=listed",
     "title": "Initiator Pharma completes dosing of the last patient in Phase 2a study of pudafensine in vulvodynia",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-09-14",
     "source": "https://view.news.eu.nasdaq.com/view?id=b9648260ae82df3a284858eccc4c7351a&lang=en&src=listed",
     "title": "Initiator Pharma strengthens its management team - appoints Annette Säfholm as COO",
     "type": "Investor News"
    },
    {
     "category": "Half year financial report",
     "date": "2026-08-21",
     "source": "https://view.news.eu.nasdaq.com/view?id=b66639f7d028af987da549dcd7ae8f0f5&lang=en&src=listed",
     "title": "INITIATOR PHARMA: Q2 2026 REPORT",
     "type": "Half year financial report"
    },
    {
     "category": "Investor News",
     "date": "2026-08-19",
     "source": "https://view.news.eu.nasdaq.com/view?id=be731641368ed3814f12c405352847394&lang=en&src=listed",
     "title": "Initiator Pharma secures two European patents for pudafensine",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-06-23",
     "source": "https://view.news.eu.nasdaq.com/view?id=b9112c8da448eed6094bc93c6ede5e248&lang=en&src=listed",
     "title": "Initiator Pharma attends BIO 2026 in San Diego",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-10-28",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/DK0060775872",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "DK0060775872"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN DK0060775872)",
    "state": "sourced",
    "value": "213800DFI4I1A5RVKB59"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Initiator Pharma A/S"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "DK0060775872"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:a49da4053db356130a1fec138e5f61a9f94f975926c2c47bcca2fcad12447c0c",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/DK0060775872",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a49da4053db356130a1fec138e5f61a9f94f975926c2c47bcca2fcad12447c0c",
 "path": "/se/SSME/DK0060775872",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Initiator Pharma A/S, listed on First North Sweden under ticker DK0060775872, with ISIN DK0060775872 and LEI 213800DFI4I1A5RVKB59. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 19 filings in the twelve months to 2026-11-06, across 15 filing days. The median gap between filing days is 20.5 days. The latest filing is dated 2026-10-28 and is of type Investor News, 9 days before the record date. The exchange median is 11.0 days of cadence gap, 21 filings and 7 days of latency across 325 issuers. Sector medians are not on the record for this market.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record, its location and any auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move events for this register. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The client category outcome is not determinable because the chapter's orderability section carries no client categories. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "Four research houses are named on the issuer's investor-relations page: DNB Carnegie, Redeye, DNB and Carnegie.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed for this market. No issuer years are sealed, the market earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/DK0060775872"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.initiatorpharma.com/en/investors/analyst-and-media-coverage/"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/DK0060775872"
  }
 ],
 "title": "Initiator Pharma A/S (DK0060775872) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}